UK markets closed
NIKKEI 225
38,946.93 -122.75 (-0.31%) HANG SENG
19,220.62 -415.60 (-2.12%) CRUDE OIL
79.06 -0.74 (-0.93%) GOLD FUTURES
2,427.60 -10.90 (-0.45%) DOW
39,883.25 +76.48 (+0.19%) Bitcoin GBP
54,602.27 -143.66 (-0.26%)
NewAmsterdam Pharma Company N.V. (NAMS)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 03:47PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.79B |
| Enterprise value | 1.30B |
| Trailing P/E | 29.99 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 242.43 |
| Price/book (mrq) | 4.34 |
| Enterprise value/revenue | 190.06 |
| Enterprise value/EBITDA | 27.63 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.08 |
| 52-week change 3 | 53.20% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 26.35 |
| 52-week low 3 | 5.63 |
| 50-day moving average 3 | 21.25 |
| 200-day moving average 3 | 14.89 |
Share statistics
| Avg vol (3-month) 3 | 189.44k |
| Avg vol (10-day) 3 | 120.08k |
| Shares outstanding 5 | 89.99M |
| Implied shares outstanding 6 | 89.99M |
| Float 8 | 30.21M |
| % held by insiders 1 | 5.73% |
| % held by institutions 1 | 84.92% |
| Shares short (30 Apr 2024) 4 | 375.02k |
| Short ratio (30 Apr 2024) 4 | 1.75 |
| Short % of float (30 Apr 2024) 4 | 0.85% |
| Short % of shares outstanding (30 Apr 2024) 4 | 0.42% |
| Shares short (prior month 28 Mar 2024) 4 | 337.88k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -3,960.17% |
Management effectiveness
| Return on assets (ttm) | -24.82% |
| Return on equity (ttm) | -54.33% |
Income statement
| Revenue (ttm) | 6.86M |
| Revenue per share (ttm) | 0.08 |
| Quarterly revenue growth (yoy) | -83.80% |
| Gross profit (ttm) | N/A |
| EBITDA | -198.54M |
| Net income avi to common (ttm) | -228.69M |
| Diluted EPS (ttm) | -2.70 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 481.15M |
| Total cash per share (mrq) | 5.35 |
| Total debt (mrq) | 43k |
| Total debt/equity (mrq) | 0.01% |
| Current ratio (mrq) | 8.17 |
| Book value per share (mrq) | 4.59 |
Cash flow statement
| Operating cash flow (ttm) | -163.96M |
| Levered free cash flow (ttm) | -82.2M |
© 2024 Yahoo. All rights reserved.